Indian Oil Corporation Q4 Profit Surges 78 as Revenue Grows 7 Board Recommends Dividend Aluminum Price Surge Amid Iran Conflict Strains Major US Companies Lifeward LFWD Q1 2026 Earnings Miss by Significant Key Takeaways Trump Pressures Bank of America JPMorgan Over Alleged Discrimination Against Conservatives EU Industrial Sovereignty at Risk Five Sectors Critically Dependent on China Gold Miners Q1 Earnings Signal Further Upside Potential in Ongoing Bull Run General Motors Introduces AllElectric Cadillac Vistiq with 300Mile Range Hybrid Village Stores An Innovative Retail Model Addressing Rural Germanys SocioEconomic Challenges RVNL Shares Fall as Q4 Profit Declines 43 YearonYear SP 500 Edges Higher as Technology and Healthcare Lead Defensive Sectors Lag MLI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Robust Demand ADAMM Q1 2026 Earnings Strong EPS Beat Driven by Investment Income ALG Q1 2026 Earnings EPS Surpasses Estimates by 828 ROP Q1 2026 Earnings EPS Beat of 258 Highlights Operational Strength USLM Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher SiriusPoint Ltd Q1 2026 Earnings EPS Surpasses Estimates by 1777 Healthcare Services Group Inc HCSG Rebounds as Support Holds Resistance Ahead Exodus Movement Inc EXOD Holds Steady at 660 in Quiet Trading Inter Co Inc INTR Faces Selling Pressure Tests Key Support at 585 Minerva Neurosciences NERV Edges Lower Near Support Level Amid Quiet Trading Launch One Acquisition Corp LPAA Holds Near Resistance With Modest Gains BiomX Inc PHGE Shares Slide 13 as Key Support Level Approaches GoodRx GDRX Holds Above Support After 288 Gain Key Levels in Focus Brookfield Property Partners Preferred Shares BPYPM Hold Steady Near Resistance as Yield Attracts Buyers Innovative Eyewear LUCY Holds Steady at 102 as Support and Resistance Levels Tighten Taylor Devices TAYD Modestly Gains as Shares Hold Above Key Support Level Bond Markets Anticipate Policy Shift as Kevin Warsh Takes Helm at Fed VOR Q1 2026 Earnings EPS Misses by Substantial Margin Amid Ongoing Pipeline Development Ironwood Pharmaceuticals IRWD Slides 49 as Support Levels Tested Near 352